Longer pollen season bringing more risk for asthma patients Research shows the hay fever season is growing longer, and one expert says GPs are at the forefront of helping patients reduce complications.
TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.
Study links childhood asthma to memory difficulties It found patients had a lower ability to remember specific events, but one GP urged caution, warning it may create ‘unnecessary concern’.
New National Sustainable Asthma Care Roadmap released Each year, Australian inhalers cause the same greenhouse impact as 350,000 cars, but experts have found a way to help both patients and the climate.
Asthma breakthrough could prevent disease development New research is paving the way for an ‘exciting’ asthma treatment after scientists isolated a molecule crucial to long-term protection.
How GPs can improve asthma outcomes and protect the environment New guidelines show switching to greener dry powder inhalers could reduce the carbon impact of asthma therapy by more than 90%, while also leading to better asthma control.
New GP resource aims to help asthma patients’ sleep The document advises doctors not to ‘accept nocturnal asthma symptoms as normal’, offering instruction for treating sleep disturbances.
Mastering asthma management and inhaler maintenance Asthma treatment has evolved but having a good management plan and keeping inhalers clean remain essential, writes Dr Kerry Hancock.
Does montelukast need a warning label? The asthma medication is known to cause behavioural and neuropsychiatric disturbance that in rare cases have been linked to suicidal ideation.
‘Completely preventable’ asthma deaths skyrocket by 32% The concerning trend saw 467 Australians die last year, but experts say most could have been avoided with the right safeguards in place.